Takeda, Cognition Kit collaborate on wearable app for depression

Takeda Pharmaceuticals and Cognition Kit, a wearable platform that monitors brain health, have partnered for a pilot study on major depressive disorder.

The study, which will involve 30 participants, will investigate the use of a specially designed app on an Apple Watch wearable. The app will collect real-time mental health data in an effort to assess cognitive function in the participants, all of whom have a clinical diagnosis of mild to moderate depression and have been prescribed an antidepressant.

The goal of the study is to understand how measures of mood and cognition on wearable technology compare to more traditional neuropsychological testing and patient-reported assessments.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars